Remed Co.,Ltd. (KOSDAQ:302550)
South Korea · Delayed Price · Currency is KRW 2,830.00
-110.00 (-3.74%)
At close: May 11, 2026
Remed Market Cap
Remed has a market cap or net worth of 87.47 billion as of May 11, 2026. Its market cap has decreased by -12.56% in one year.
Market Cap
87.47B
Enterprise Value
81.86B
Revenue
24.50B
Ranking
n/a
PE Ratio
166.23
Stock Price
2,830.00
Market Cap Chart
Since August 14, 2018, Remed's market cap has increased from 73.83B to 87.47B, an increase of 18.46%. That is a compound annual growth rate of 2.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 90.87B | -4.23% |
| Dec 30, 2025 | 94.88B | -13.97% |
| Dec 30, 2024 | 110.30B | 10.60% |
| Dec 28, 2023 | 99.73B | 31.78% |
| Dec 29, 2022 | 75.68B | -53.48% |
| Dec 30, 2021 | 162.69B | -18.29% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| L&K Biomed | 138.80B |
| SELVAS Healthcare | 106.21B |
| Hironic | 95.63B |
| Dynamic solution | 93.74B |
| QuantaMatrix | 77.62B |
| Noul Co.,Ltd. | 62.63B |
| DRGEM | 60.58B |
| Genoray | 59.83B |